YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression

Cited by papers we hold 10

• Hepatocellular carcinoma: signaling pathways and therapeutic advances · 2025
  No notice
• Emerging Therapies for Hepatocellular Carcinoma (HCC) · 2022
  No notice
• Pharmacological blockade of TEAD–YAP reveals its therapeutic limitation in cancer cells · 2022
  No notice
• Analysis of the role of the Hippo pathway in cancer · 2019
  No notice
• NUAK2 is a critical YAP target in liver cancer · 2018
  No notice
• Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer · 2018
  No notice
• Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells · 2017
  No notice
• Platelets reduce anoikis and promote metastasis by activating YAP1 signaling · 2017
  No notice
• Induction of Expandable Tissue-Specific Stem/Progenitor Cells through Transient Expression of YAP/TAZ · 2016
  No notice
• LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.